Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

41 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Development of a Prediction Model for Short-Term Remission of Patients with Crohn's Disease Treated with Anti-TNF Drugs.
Medina-Medina R, Iglesias-Flores E, Benítez JM, Marín-Pedrosa S, Salgueiro-Rodríguez I, Linares CI, González-Rubio S, Soto-Escribano P, Gros B, Rodríguez-Perálvarez ML, Cabriada JL, Chaparro M, Gisbert JP, Chicano-Gálvez E, Ortea I, Ferrín G, García-Sánchez V, Aguilar-Melero P. Medina-Medina R, et al. Among authors: iglesias flores e. Int J Mol Sci. 2023 May 12;24(10):8695. doi: 10.3390/ijms24108695. Int J Mol Sci. 2023. PMID: 37240037 Free PMC article.
Evolution after switching to biosimilar infliximab in inflammatory bowel disease patients in clinical remission.
Guerrero Puente L, Iglesias Flores E, Benítez JM, Medina Medina R, Salgueiro Rodríguez I, Aguilar Melero P, Cárdenas Aranzana MJ, González Fernández R, Manzanares Martin B, García-Sánchez V. Guerrero Puente L, et al. Gastroenterol Hepatol. 2017 Nov;40(9):595-604. doi: 10.1016/j.gastrohep.2017.07.005. Epub 2017 Aug 31. Gastroenterol Hepatol. 2017. PMID: 28865888 English, Spanish.
Fendrix vs Engerix-B for Primo-Vaccination Against Hepatitis B Infection in Patients With Inflammatory Bowel Disease: A Randomized Clinical Trial.
Chaparro M, Gordillo J, Domènech E, Esteve M, Barreiro-de Acosta M, Villoria A, Iglesias-Flores E, Blasi M, Naves JE, Benítez O, Nieto L, Calvet X, García-Sánchez V, Villagrasa JR, Marin AC, Donday MG, Abad-Santos F, Gisbert JP. Chaparro M, et al. Among authors: iglesias flores e. Am J Gastroenterol. 2020 Nov;115(11):1802-1811. doi: 10.14309/ajg.0000000000000926. Am J Gastroenterol. 2020. PMID: 33156099 Free article. Clinical Trial.
Long-Term Real-World Effectiveness and Safety of Ustekinumab in Crohn's Disease Patients: The SUSTAIN Study.
Chaparro M, Baston-Rey I, Fernández-Salgado E, González García J, Ramos L, Diz-Lois Palomares MT, Argüelles-Arias F, Iglesias Flores E, Cabello M, Rubio Iturria S, Núñez Ortiz A, Charro M, Ginard D, Dueñas Sadornil C, Merino Ochoa O, Busquets D, Iyo E, Gutiérrez Casbas A, Ramírez de la Piscina P, Boscá-Watts MM, Arroyo M, García MJ, Hinojosa E, Gordillo J, Martínez Montiel P, Velayos Jiménez B, Quílez Ivorra C, Vázquez Morón JM, María Huguet J, González-Lama Y, Muñagorri Santos AI, Amo VM, Martín-Arranz MD, Bermejo F, Martínez Cadilla J, Rubín de Célix C, Fradejas Salazar P, San Román AL, Jiménez N, García López S, Figuerola A, Jiménez I, Martínez Cerezo FJ, Taxonera C, Varela P, de Francisco R, Monfort D, Molina Arriero G, Hernández Camba A, García-Alonso FJ, Van Domselaar M, Pajares Villarroya R, Núñez A, Rodríguez Moranta F, Marín-Jiménez I, Robles Alonso V, Martín Rodríguez MDM, Camo-Monterde P, García Tercero I, Navarro Llavat M, Arias García L, Hervías Cruz D, Sulleiro S, Novella C, Vispo E, Barreiro-de Acosta M, Gisbert JP. Chaparro M, et al. Among authors: iglesias flores e. Inflamm Bowel Dis. 2022 Nov 2;28(11):1725-1736. doi: 10.1093/ibd/izab357. Inflamm Bowel Dis. 2022. PMID: 35166347 Free PMC article.
Prevalence of iron deficiency without anaemia in inflammatory bowel disease and impact on health-related quality of life.
González Alayón C, Pedrajas Crespo C, Marín Pedrosa S, Benítez JM, Iglesias Flores E, Salgueiro Rodríguez I, Medina Medina R, García-Sánchez V. González Alayón C, et al. Gastroenterol Hepatol. 2018 Jan;41(1):22-29. doi: 10.1016/j.gastrohep.2017.07.011. Epub 2017 Sep 9. Gastroenterol Hepatol. 2018. PMID: 28899570 English, Spanish.
Clinical outcome after anti-tumour necrosis factor therapy discontinuation in 1000 patients with inflammatory bowel disease: the EVODIS long-term study.
Casanova MJ, Chaparro M, Nantes Ó, Benítez JM, Rojas-Feria M, Castro-Poceiro J, Huguet JM, Martín-Cardona A, Aicart-Ramos M, Tosca J, Martín-Rodríguez MDM, González-Muñoza C, Mañosa M, Leo-Carnerero E, Lamuela-Calvo LJ, Pérez-Martínez I, Bujanda L, Hinojosa J, Pajares R, Argüelles-Arias F, Pérez-Calle JL, Rodríguez-González GE, Guardiola J, Barreiro-de Acosta M, Gisbert JP; EVODIS Study Group*. Casanova MJ, et al. Aliment Pharmacol Ther. 2021 Jun;53(12):1277-1288. doi: 10.1111/apt.16361. Epub 2021 May 7. Aliment Pharmacol Ther. 2021. PMID: 33962482
Can systemic cytokines predict relapse of inflammatory bowel disease?
García-Sánchez V, González R, Iglesias-Flores E, Gisbert JP, Angel-Rey JM, Soto-Escribano P, Gálvez-Calderón C, Reyes-López A, Pérez-Jiménez F, de Dios-Vega JF, Muntané J, Gómez-Camacho F. García-Sánchez V, et al. Hepatogastroenterology. 2010 May-Jun;57(99-100):524-30. Hepatogastroenterology. 2010. PMID: 20698221
Mesalazine induced interstitial pneumonitis in the COVID era.
Aparicio Serrano A, Gallego Jiménez E, Castro Rodríguez J, Soto Escribano P, Iglesias Flores E, Marín Pedrosa S, Benítez JM. Aparicio Serrano A, et al. Among authors: iglesias flores e. Rev Esp Enferm Dig. 2022 Jul;114(7):429-430. doi: 10.17235/reed.2022.8635/2021. Rev Esp Enferm Dig. 2022. PMID: 35199533 Free article.
41 results